Form 4: Aadi Bioscience Insider Filing: Avoro Capital Advisors Acquires Stock Options

Behzad Aghazadeh, along with Avoro Capital Advisors and Avoro Ventures, reports the acquisition of stock options in Aadi Bioscience, Inc.

Summary

• This Form 4 filing reports changes in beneficial ownership of Aadi Bioscience, Inc. (AADI) securities.
• The reporting persons are Behzad Aghazadeh, Avoro Capital Advisors LLC, and Avoro Ventures LLC.
• The filing indicates the acquisition of 45,832 stock options with an exercise price of $1.70 on June 12, 2024, expiring on June 12, 2034.
• These options vest on the earlier of the one-year anniversary of the grant date or the day before the next annual meeting, contingent on continued service.
• The reporting persons disclaim beneficial ownership except to the extent of their pecuniary interest.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating insider activity, which can be seen as a mild positive, but the disclaimers temper any strong positive interpretation.

Positives

• The acquisition of stock options by insiders could be interpreted as a positive sign, indicating confidence in the company's future performance.

Risks

• The filing includes disclaimers of beneficial ownership, which could indicate uncertainty about the level of control or influence the reporting persons have over the securities.

Future Outlook

The document does not contain specific forward-looking statements about Aadi Bioscience's future performance, but the vesting of the options is tied to continued service, suggesting a long-term commitment.

Management Comments

• Dr. Aghazadeh serves as the portfolio manager and controlling person of Avoro Capital Advisors and Avoro Ventures LLC.
• Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding insider transactions. This filing indicates activity by a significant shareholder and director, which is relevant to investors monitoring the stock.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their insiders.
• The vesting schedule of the options (one year or prior to the next annual meeting) is a common structure for equity compensation.
• Disclaimers of beneficial ownership are also common when entities like investment advisors are involved.

Stakeholder Impact

• Shareholders may view the insider activity as a sign of confidence or may be concerned about potential dilution from the exercise of the options.
• Employees who are also option holders may be encouraged by the insider's participation in the equity incentive plan.

Key Dates